FRISCO, Texas--(BUSINESS WIRE)--Mar. 15, 2013--
As previously announced, Greatbatch, Inc. (NYSE:GB) will host a meeting
for institutional investors and research analysts on Monday, March 18,
2013 from 12:00 p.m. to 5:00 p.m. ET at the Millennium Broadway Hotel,
New York, New York.
At this half day session, Greatbatch President and CEO, Thomas J. Hook
and Senior Vice President and CFO, Michael Dinkins will discuss the
company’s core business and how it is driving organic growth and
financial performance. They will also provide a comprehensive review of
Algostim, an innovative, internally developed spinal cord stimulation
system which is nearing completion. In addition, 2013 financial guidance
will be reviewed along with an outlook of long term growth prospects.
A live webcast of the presentation commences at 1:00 p.m. ET and will be
available via a link on the Investor Relations page of the Company's
website at http://www.greatbatch.com/.
About Greatbatch, Inc.
Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to
industries that depend on reliable, long-lasting performance through its
brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical
develops and manufactures critical medical device technologies for the
cardiac, neuromodulation, vascular and orthopaedic markets. Electrochem
designs and manufactures batteries for high-end niche applications in
the portable medical, energy, military, and other markets. The QiG Group
empowers the design and development of new medical devices for our core
markets. Additional information about the Company is available at www.greatbatch.com.
Source: Greatbatch, Inc.
Greatbatch, Inc.
Investor Relations:
Michael Dinkins,
214-618-5242
mdinkins@greatbatch.com
or
Media:
Christopher
Knospe, 716-759-5727
cknospe@greatbatch.com